Table 8 The top 10 candidate circRNAs identified by GDCL-NcDA for (1) cervical cancer and (2) breast cancer
Ranking | circRNAs of (1) | Evidence |
1 | hsa\(\_\)circ\(\_\)0002113 | â‘£ |
2 | hsa\(\_\)circ\(\_\)0061893 | Unconfirmed |
3 | hsa\(\_\)circ\(\_\)0004771 | â‘¢/â‘£ |
4 | hsa\(\_\)circ\(\_\)0043138 | â‘£ |
5 | hsa\(\_\)circ\(\_\)101396 | Unconfirmed |
6 | hsa\(\_\)circ\(\_\)103783 | Unconfirmed |
7 | hsa\(\_\)circ\(\_\)102533 | Unconfirmed |
8 | hsa\(\_\)circ\(\_\)102470 | Unconfirmed |
9 | hsa\(\_\)circ\(\_\)0023984 | â‘£ |
10 | hsa\(\_\)circ\(\_\)0007534 | ③/⑤ |
Ranking | circRNAs of (2) | Evidence |
1 | hsa\(\_\)circ\(\_\)0000064 | Unconfirmed |
2 | hsa\(\_\)circ\(\_\)0014717 | â‘£ |
3 | hsa\(\_\)circ\(\_\)102231 | Unconfirmed |
4 | hsa\(\_\)circ\(\_\)103595 | Unconfirmed |
5 | hsa\(\_\)circ\(\_\)104964 | Unconfirmed |
6 | hsa\(\_\)circ\(\_\)0000615 | ③/④/⑤ |
7 | hsa\(\_\)circ\(\_\)0030045 | â‘£ |
8 | hsa\(\_\)circ\(\_\)001937 | Unconfirmed |
9 | hsa\(\_\)circ\(\_\)0001417 | â‘£ |
10 | hsa\(\_\)circ\(\_\)100290 | â‘£ |